Reports on the need for the European Agency for the Evaluation of Medicinal Products (EAEMP) to reform its drug approval mechanism. Appeal filed by drug company PharMar to overturn the decision of EAEMP not to approve Yondelis, a treatment for soft tissue sarcoma; Proposals to change the way EAEMP handle new drug approval applications.